Digital Pathology and Artificial Intelligence applied to Precision Medicine: use cases from AstraZeneca

Treatment decisions in oncology are commonly informed by the visual assessment of immunohistochemistry biomarkers by pathologists. However, pathology services face mounting pressure as diagnostic demand increases and workforce decreases. Digital pathology and artificial intelligence have the potential to streamline the diagnostic workflow thereby improving pathologists’ workload, accelerating turn-around-times and facilitating access to testing. Here, we … Czytaj dalej Digital Pathology and Artificial Intelligence applied to Precision Medicine: use cases from AstraZeneca